Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Resolved | 2018-10-25 | 2018-12-08 | 65595 |
| APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Resolved | 2019-09-18 | 2019-12-19 | 94168 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2020-03-27 | 2020-07-06 | 109678 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2018-09-04 | 2019-05-13 | 59813 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2023-05-19 | 2023-06-16 | 192815 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-10-11 | 311 |
| APO-ERLOTINIB | 100MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74875 |
| APO-ERLOTINIB | 150MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74878 |
| APO-ERLOTINIB | 25MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74881 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77878 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77881 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-06 | 2019-03-09 | 77971 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-06-26 | 2020-01-20 | 87517 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-11-30 | 2019-02-08 | 68218 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-12-12 | 2019-02-26 | 69299 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111909 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-01-08 | 2021-01-26 | 131157 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134814 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-08-29 | 2024-10-25 | 236243 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |